TC BioPharm (Holdings) plc American Depositary Shares
TCBP
TCBP was delisted on the 21st of March, 2025.
0 hedge funds and large institutions have $0 invested in TC BioPharm (Holdings) plc American Depositary Shares in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $1 → $0 (-$1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
RhumbLine Advisers
Boston,
Massachusetts
| – | -$1 | -5 | Closed |
|
TCBP Hedge Fund Activity: Q4 2025 in Review
0 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc American Depositary Shares (TCBP) for Q4 2025, worth a combined $0 — down 100% from $1 a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of TCBP and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was RhumbLine Advisers, exiting entirely with an estimated $1 sold.
- 0 institutional investors held TC BioPharm (Holdings) plc American Depositary Shares (TCBP) as of Q4 2025, down from 1 in Q3 2025.
- Funds reported $0 of TC BioPharm (Holdings) plc American Depositary Shares stock for Q4 2025, down 100% quarter-over-quarter.
- 0 funds opened new TC BioPharm (Holdings) plc American Depositary Shares positions in Q4 2025 and 1 closed out, a net change of -1 holder.
- The largest TC BioPharm (Holdings) plc American Depositary Shares seller in Q4 2025 was RhumbLine Advisers, an estimated $1 sold.
Based on aggregated 13F filings for Q4 2025.